10 20 30 40 50 60 70 80 1X0J - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSCRIPTION 23-MAR-05 1X0J
TITLE CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF TITLE 2 HUMAN BRD2
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN; COMPND 5 SYNONYM: BRD2, RING3 PROTEIN, O27.1.1; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCR2.1-TOPO VECTOR; SOURCE 9 OTHER_DETAILS: EXPRESSED BY CELL-FREE EXPRESSION METHOD
KEYWDS ALPHA-HELICAL DOMAIN, BROMODOMAIN, BINDS TO ACETYLATED KEYWDS 2 HISTONES, STRUCTURAL GENOMICS, RIKEN STRUCTURAL KEYWDS 3 GENOMICS/PROTEOMICS INITIATIVE, RSGI, NPPSFA, NATIONAL KEYWDS 4 PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, KEYWDS 5 TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.NAKAMURA,T.UMEHARA,M.SHIROUZU,B.PADMANABHAN,S.YOKOYAMA, AUTHOR 2 RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI)
REVDAT 2 24-FEB-09 1X0J 1 VERSN REVDAT 1 27-JUN-06 1X0J 0
JRNL AUTH Y.NAKAMURA,T.UMEHARA,M.SHIROUZU,B.PADMANABHAN, JRNL AUTH 2 S.YOKOYAMA JRNL TITL STRUCTURAL BASIS FOR ACETYLATED HISTONE H4 JRNL TITL 2 RECOGNITION BY THE HUMAN BRD2 BROMODOMAIN JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 34340 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1806 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1234 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE : 0.3910 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 75 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 352 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.04000 REMARK 3 B22 (A**2) : -0.18000 REMARK 3 B33 (A**2) : -0.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1X0J COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-MAR-05. REMARK 100 THE RCSB ID CODE IS RCSB024226.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36172 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEGMME 5K, AS, PH 6.5, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.19850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.68150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.19850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.68150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 114.39700 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1398 O HOH A 1403 2.15 REMARK 500 O HOH C 1421 O HOH C 1444 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 122 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP B 160 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 160 CB - CG - OD1 ANGL. DEV. = 8.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 182 57.94 -114.49 REMARK 500 GLU A 184 93.80 -39.36 REMARK 500 VAL B 75 119.43 77.03 REMARK 500 VAL C 85 -54.35 -123.21 REMARK 500 LEU C 110 68.41 -115.14 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C1490 DISTANCE = 7.76 ANGSTROMS REMARK 525 HOH A1398 DISTANCE = 6.66 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTT A 1301 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTT B 1302 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTT C 1303 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES C 1401
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: AR_001000221 RELATED DB: TARGETDB
DBREF 1X0J A 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 1X0J B 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 1X0J C 73 194 UNP P25440 BRD2_HUMAN 73 194
SEQADV 1X0J MSE A 87 UNP P25440 MET 87 MODIFIED RESIDUE SEQADV 1X0J MSE A 121 UNP P25440 MET 121 MODIFIED RESIDUE SEQADV 1X0J MSE A 123 UNP P25440 MET 123 MODIFIED RESIDUE SEQADV 1X0J MSE A 142 UNP P25440 MET 142 MODIFIED RESIDUE SEQADV 1X0J MSE A 148 UNP P25440 MET 148 MODIFIED RESIDUE SEQADV 1X0J MSE A 165 UNP P25440 MET 165 MODIFIED RESIDUE SEQADV 1X0J MSE A 180 UNP P25440 MET 180 MODIFIED RESIDUE SEQADV 1X0J MSE B 87 UNP P25440 MET 87 MODIFIED RESIDUE SEQADV 1X0J MSE B 121 UNP P25440 MET 121 MODIFIED RESIDUE SEQADV 1X0J MSE B 123 UNP P25440 MET 123 MODIFIED RESIDUE SEQADV 1X0J MSE B 142 UNP P25440 MET 142 MODIFIED RESIDUE SEQADV 1X0J MSE B 148 UNP P25440 MET 148 MODIFIED RESIDUE SEQADV 1X0J MSE B 165 UNP P25440 MET 165 MODIFIED RESIDUE SEQADV 1X0J MSE B 180 UNP P25440 MET 180 MODIFIED RESIDUE SEQADV 1X0J MSE C 87 UNP P25440 MET 87 MODIFIED RESIDUE SEQADV 1X0J MSE C 121 UNP P25440 MET 121 MODIFIED RESIDUE SEQADV 1X0J MSE C 123 UNP P25440 MET 123 MODIFIED RESIDUE SEQADV 1X0J MSE C 142 UNP P25440 MET 142 MODIFIED RESIDUE SEQADV 1X0J MSE C 148 UNP P25440 MET 148 MODIFIED RESIDUE SEQADV 1X0J MSE C 165 UNP P25440 MET 165 MODIFIED RESIDUE SEQADV 1X0J MSE C 180 UNP P25440 MET 180 MODIFIED RESIDUE
SEQRES 1 A 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 A 122 VAL MSE LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 A 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 A 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MSE ASP MSE GLY SEQRES 5 A 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 A 122 ALA SER GLU CYS MSE GLN ASP PHE ASN THR MSE PHE THR SEQRES 7 A 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 A 122 LEU MSE ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 A 122 VAL ALA SER MSE PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 A 122 THR ILE PRO LYS ASN SEQRES 1 B 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 B 122 VAL MSE LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 B 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 B 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MSE ASP MSE GLY SEQRES 5 B 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 B 122 ALA SER GLU CYS MSE GLN ASP PHE ASN THR MSE PHE THR SEQRES 7 B 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 B 122 LEU MSE ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 B 122 VAL ALA SER MSE PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 B 122 THR ILE PRO LYS ASN SEQRES 1 C 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 C 122 VAL MSE LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 C 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 C 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MSE ASP MSE GLY SEQRES 5 C 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 C 122 ALA SER GLU CYS MSE GLN ASP PHE ASN THR MSE PHE THR SEQRES 7 C 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 C 122 LEU MSE ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 C 122 VAL ALA SER MSE PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 C 122 THR ILE PRO LYS ASN
MODRES 1X0J MSE A 87 MET SELENOMETHIONINE MODRES 1X0J MSE A 121 MET SELENOMETHIONINE MODRES 1X0J MSE A 123 MET SELENOMETHIONINE MODRES 1X0J MSE A 142 MET SELENOMETHIONINE MODRES 1X0J MSE A 148 MET SELENOMETHIONINE MODRES 1X0J MSE A 165 MET SELENOMETHIONINE MODRES 1X0J MSE A 180 MET SELENOMETHIONINE MODRES 1X0J MSE B 87 MET SELENOMETHIONINE MODRES 1X0J MSE B 121 MET SELENOMETHIONINE MODRES 1X0J MSE B 123 MET SELENOMETHIONINE MODRES 1X0J MSE B 142 MET SELENOMETHIONINE MODRES 1X0J MSE B 148 MET SELENOMETHIONINE MODRES 1X0J MSE B 165 MET SELENOMETHIONINE MODRES 1X0J MSE B 180 MET SELENOMETHIONINE MODRES 1X0J MSE C 87 MET SELENOMETHIONINE MODRES 1X0J MSE C 121 MET SELENOMETHIONINE MODRES 1X0J MSE C 123 MET SELENOMETHIONINE MODRES 1X0J MSE C 142 MET SELENOMETHIONINE MODRES 1X0J MSE C 148 MET SELENOMETHIONINE MODRES 1X0J MSE C 165 MET SELENOMETHIONINE MODRES 1X0J MSE C 180 MET SELENOMETHIONINE
HET MSE A 87 8 HET MSE A 121 8 HET MSE A 123 8 HET MSE A 142 8 HET MSE A 148 8 HET MSE A 165 8 HET MSE A 180 8 HET MSE B 87 8 HET MSE B 121 8 HET MSE B 123 8 HET MSE B 142 8 HET MSE B 148 8 HET MSE B 165 8 HET MSE B 180 8 HET MSE C 87 8 HET MSE C 121 8 HET MSE C 123 8 HET MSE C 142 8 HET MSE C 148 8 HET MSE C 165 8 HET MSE C 180 8 HET DTT A1301 8 HET DTT B1302 8 HET DTT C1303 8 HET MES C1401 12
HETNAM MSE SELENOMETHIONINE HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
HETSYN DTT 1,4-DITHIOTHREITOL
FORMUL 1 MSE 21(C5 H11 N O2 SE) FORMUL 4 DTT 3(C4 H10 O2 S2) FORMUL 7 MES C6 H13 N O4 S FORMUL 8 HOH *352(H2 O)
HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 HIS A 93 1 9 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 HIS B 93 1 9 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 104 GLY B 109 1 6 HELIX 13 13 ASP B 112 ILE B 117 1 6 HELIX 14 14 ASP B 122 ASN B 132 1 11 HELIX 15 15 ALA B 137 ASN B 156 1 20 HELIX 16 16 ASP B 160 ALA B 178 1 19 HELIX 17 17 THR C 76 VAL C 85 1 10 HELIX 18 18 VAL C 85 HIS C 93 1 9 HELIX 19 19 GLN C 94 ARG C 100 5 7 HELIX 20 20 ASP C 112 ILE C 117 1 6 HELIX 21 21 ASP C 122 ASN C 132 1 11 HELIX 22 22 ALA C 137 ASN C 156 1 20 HELIX 23 23 ASP C 160 SER C 179 1 20
LINK C VAL A 86 N MSE A 87 1555 1555 1.30 LINK C MSE A 87 N LYS A 88 1555 1555 1.34 LINK C PRO A 120 N MSE A 121 1555 1555 1.34 LINK C MSE A 121 N ASP A 122 1555 1555 1.33 LINK C ASP A 122 N MSE A 123 1555 1555 1.33 LINK C MSE A 123 N GLY A 124 1555 1555 1.32 LINK C CYS A 141 N MSE A 142 1555 1555 1.33 LINK C MSE A 142 N GLN A 143 1555 1555 1.32 LINK C THR A 147 N MSE A 148 1555 1555 1.34 LINK C MSE A 148 N PHE A 149 1555 1555 1.32 LINK C LEU A 164 N MSE A 165 1555 1555 1.31 LINK C MSE A 165 N ALA A 166 1555 1555 1.32 LINK C SER A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N PRO A 181 1555 1555 1.33 LINK C VAL B 86 N MSE B 87 1555 1555 1.32 LINK C MSE B 87 N LYS B 88 1555 1555 1.31 LINK C PRO B 120 N MSE B 121 1555 1555 1.32 LINK C MSE B 121 N ASP B 122 1555 1555 1.33 LINK C ASP B 122 N MSE B 123 1555 1555 1.35 LINK C MSE B 123 N GLY B 124 1555 1555 1.32 LINK C CYS B 141 N MSE B 142 1555 1555 1.35 LINK C MSE B 142 N GLN B 143 1555 1555 1.33 LINK C THR B 147 N MSE B 148 1555 1555 1.33 LINK C MSE B 148 N PHE B 149 1555 1555 1.32 LINK C LEU B 164 N MSE B 165 1555 1555 1.32 LINK C MSE B 165 N ALA B 166 1555 1555 1.33 LINK C SER B 179 N MSE B 180 1555 1555 1.31 LINK C MSE B 180 N PRO B 181 1555 1555 1.31 LINK C VAL C 86 N MSE C 87 1555 1555 1.32 LINK C MSE C 87 N LYS C 88 1555 1555 1.33 LINK C PRO C 120 N MSE C 121 1555 1555 1.32 LINK C MSE C 121 N ASP C 122 1555 1555 1.32 LINK C ASP C 122 N MSE C 123 1555 1555 1.33 LINK C MSE C 123 N GLY C 124 1555 1555 1.32 LINK C CYS C 141 N MSE C 142 1555 1555 1.30 LINK C MSE C 142 N GLN C 143 1555 1555 1.34 LINK C THR C 147 N MSE C 148 1555 1555 1.31 LINK C MSE C 148 N PHE C 149 1555 1555 1.32 LINK C LEU C 164 N MSE C 165 1555 1555 1.33 LINK C MSE C 165 N ALA C 166 1555 1555 1.33 LINK C SER C 179 N MSE C 180 1555 1555 1.32 LINK C MSE C 180 N PRO C 181 1555 1555 1.34
SITE 1 AC1 6 VAL A 103 LEU A 108 TYR A 113 ASN A 156 SITE 2 AC1 6 ILE A 162 HOH A1303 SITE 1 AC2 7 LEU B 108 TYR B 113 ASN B 156 ILE B 162 SITE 2 AC2 7 HOH B1306 HOH B1345 HOH B1398 SITE 1 AC3 8 GLN B 80 PRO C 98 VAL C 103 LEU C 108 SITE 2 AC3 8 ASN C 156 ILE C 162 HOH C1403 HOH C1417 SITE 1 AC4 6 TRP A 97 ARG A 100 ARG C 128 ASN C 132 SITE 2 AC4 6 TYR C 134 HOH C1484
CRYST1 114.397 55.363 67.584 90.00 94.07 90.00 C 1 2 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008741 0.000000 0.000622 0.00000
SCALE2 0.000000 0.018063 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014834 0.00000